Suppression of GPR56 Expression by Pyrrole-Imidazole Polyamide Represents a Novel Therapeutic Drug for AML With High EVI1 Expression

Scientific Reports - United Kingdom
doi 10.1038/s41598-018-32205-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

miR-133 Regulates Evi1 Expression in AML Cells as a Potential Therapeutic Target

Scientific Reports
Multidisciplinary
2016English

A Pyrrole-Imidazole Polyamide Is Active Against Enzalutamide-Resistant Prostate Cancer

Cancer Research
Cancer ResearchOncology
2017English

Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for Immunotherapy

Applied Immunohistochemistry and Molecular Morphology
Forensic MedicinePathologyMedical Laboratory TechnologyHistology
2016English

Inhibition of MMP-9 Using a Pyrrole-Imidazole Polyamide Reduces Cell Invasion in Renal Cell Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2013English

Tandem Trimer Pyrrole–imidazole Polyamide Probes Targeting 18 Base Pairs in Human Telomere Sequences

Chemical Science
Chemistry
2015English

Maintenance of the Hematopoietic Stem Cell Pool in Bone Marrow Niches by EVI1-regulated GPR56

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2013English

In Vitro Transformation of Primary Human CD34+ Cells by AML Fusion Oncogenes: Early Gene Expression Profiling Reveals Possible Drug Target in AML

PLoS ONE
Multidisciplinary
2010English

Quantitative Radiomic Profiling of Glioblastoma Represents Transcriptomic Expression

Oncotarget
Oncology
2018English

Preclinical Study of DNA-Recognized Peptide Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in Common Marmoset

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy